Loading insider details...
Beta
Latest Form 4 (Aug 19, 2026): Sale of 7,000 CADL shares, $84.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Candel Therapeutics, Inc. (CADL) | Sale | 7,000 | $84.0K |
| Jul 1, 2026 | Candel Therapeutics, Inc. (CADL) | Sale | 7,000 | $70.2K |
| Jan 28, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 154,000 | n/a |
| Jun 26, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 5,353 | $25.0K |
| Mar 19, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 31,278 | $275.9K |
| Feb 14, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 65,000 | n/a |
| Jan 17, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 14,322 | $103.5K |
| Jan 10, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 14,545 | $119.5K |
| Dec 3, 2024 | Candel Therapeutics, Inc. (CADL) | Sale | 20,392 | $92.9K |
| Jul 19, 2024 | Candel Therapeutics, Inc. (CADL) | Sale | 14,851 | $96.1K |